UNSPSC 51411614: Dilevalol hydrochloride

This classification denotes a vasodilating agent and adrenergic antagonist with the molecular structure C19H24N2O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, O5OBT75D2C chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride, (r-(r*,r*))-, but more commonly known as dilevalol hydrochloride, which bears US NIH Compound Identifier 636407.

European Medicines Agency schedules Dilevalol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01734MIG. Most nations, for tariff and trade purposes, schedule dilevalol hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, DILEVALOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CCC1CCCCC1)NC[C@@H](C2CCC(C(C2)C(=O)N)O)O.CL.

UNSPSC 51411614 Dilevalol hydrochloride is a Commodity code that covers pharmaceutical products, specifically beta-blocker medications used in emergency medical response and acute care settings. State and local governments acquire these medications through their fire, rescue, and emergency medical services departments for use in advanced life support protocols. The City of Tampa's recent solicitation for Advanced Life Support Medications illustrates the actual scope: municipalities source specific medication vials and injections including labetalol hydrochloride, epinephrine, adenosine, and diltiazem for paramedic and emergency responder use. Issuing bodies under this code are primarily municipal fire and rescue departments and their procurement offices; the solicitations are typically invitational bids (IFB) or sealed-bid procurements issued by city purchasing departments on behalf of emergency medical services divisions. Vendors must meet strict pharmaceutical compliance requirements including OSHA Safety Data Sheets, product warranties, controlled expiration-date management, and accessibility standards; contract terms generally run one year with renewal options, and award goes to the lowest responsive, responsible bidder.

The City of Tampa, Florida posted sealed-bid solicitation 26P00188 on April 24, 2026, with a response deadline of April 8, 2026, seeking Advanced Life Support Medications for Tampa Fire Rescue in Hillsborough County. The estimated contract value is $40,000.00. The solicitation included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount for SLBE participation, not to exceed $10,000. Recent opportunities under this code appear limited to municipal fire and rescue procurement in Florida; the source provides no evidence of wider geographic activity or repeat solicitations by other jurisdictions in the dataset.